Cargando…

Novel Therapeutic Drugs for Neuropsychiatric Disorders

Detalles Bibliográficos
Autor principal:	Hashimoto, Kenji
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909564/ https://www.ncbi.nlm.nih.gov/pubmed/20661321 http://dx.doi.org/10.2174/1874104501004020001

Ejemplares similares

Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders
por: Shan, Jiajing, et al.
Publicado: (2022)

New horizon for the therapeutic modality of exercise on neuropsychiatric disorders
por: Kim, Chang-Ju
Publicado: (2013)

The role of sex and gender in neuropsychiatric disorders
por: Thibaut, Florence
Publicado: (2016)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Anti-apoptotic effect of exercise on neuropsychiatric disorders
por: Kim, Chang-Ju
Publicado: (2014)

The Many Faces of Stress: Implications for Neuropsychiatric Disorders
por: Musazzi, Laura, et al.
Publicado: (2016)

The Role of Dentate Gyrus Neurogenesis in Neuropsychiatric Disorders
por: García-Fuster, M. Julia, et al.
Publicado: (2013)

Clinical Neurophysiology, Neuroimaging, and Neuromodulation of Neuropsychiatric Disorders
por: Noda, Yoshihiro
Publicado: (2021)

New Advances in Neuropsychiatric Disorders of Childhood and Adolescence
por: Roccella, Michele, et al.
Publicado: (2022)

Genetics and epigenetics as tools to inform the pathophysiology of neuropsychiatric disorders
por: Fries, Gabriel Rodrigo
Publicado: (2019)

Neurobiology of Behavior—Influences of Neuropsychiatric Disorders on Neurobiology and Behavior
por: Fakhoury, Marc, et al.
Publicado: (2023)

Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention
por: Hashimoto, Kenji
Publicado: (2020)

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
por: Bazzari, Amjad H., et al.
Publicado: (2022)

Therapeutic Potential of the Microbiome in the Treatment of Neuropsychiatric Disorders
por: Evrensel, Alper, et al.
Publicado: (2019)

A promising era for epigenetic research: revealing the molecular signature of neuropsychiatric disorders
por: Viola, Thiago Wendt, et al.
Publicado: (2019)

Major channels involved in neuropsychiatric disorders and therapeutic perspectives
por: Imbrici, Paola, et al.
Publicado: (2013)

Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
por: Schiavone, Stefania, et al.
Publicado: (2018)

Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders
por: Zhang, Sen, et al.
Publicado: (2023)

Mysteries of pedunculopontine nucleus physiology: Towards a deeper understanding of arousal and neuropsychiatric disorders()
por: Datta, Subimal
Publicado: (2015)

EDITORIAL Ultrasonic Vocalizations in Rats: A Tool for the Investigation of Psychoactive Drugs and Neuropsychiatric Conditions
por: (Guest Editor), Simola Nicola
Publicado: (2015)

Mental health during the COVID-19 pandemic, impact of childhood trauma in psychiatric disorders, and predictable biomarkers for bipolar disorder
por: Hashimoto, Kenji
Publicado: (2022)

Editorial: Perineuronal Nets as Therapeutic Targets for the Treatment of Neuropsychiatric Disorders
por: Browne, Caroline A., et al.
Publicado: (2022)

Neuroinflammation: new vistas for neuropsychiatric research
por: Thibaut, Florence
Publicado: (2017)

International Neuropsychiatric Association
por: Sachdev, Perminder
Publicado: (2005)

Reelin and Neuropsychiatric Disorders
por: Ishii, Kazuhiro, et al.
Publicado: (2016)

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

The genetics of neuropsychiatric disorders
por: Bray, Nicholas J., et al.
Publicado: (2018)

The relationship between multiple sclerosis and neuropsychiatric syndromes
por: McLoughlin, James, et al.
Publicado: (2017)

Cultural modification of neuropsychiatric assessment: complexities to consider
por: Tanveer, Sandila, et al.
Publicado: (2022)

The importance of co-pathologies on neuropsychiatric symptoms in dementia
por: Gibson, Lucy L., et al.
Publicado: (2022)

The Unfolded Protein Response and Autophagy as Drug Targets in Neuropsychiatric Disorders
por: Srinivasan, Vignesh, et al.
Publicado: (2020)

Periorbital injections of botulinum toxin a: a novel therapeutic option for convergence spasm in neuropsychiatric disorders
por: Hess, Kristina, et al.
Publicado: (2021)

Editorial: Glia-Neuron Crosstalk and its Therapeutic Implication in Neuropsychiatric Disorders
por: Kim, Yong-Ku, et al.
Publicado: (2018)

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
por: Muneer, Ather
Publicado: (2020)

Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
por: Cid-Jofré, Valeska, et al.
Publicado: (2021)

Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update
por: Asgharian, Parina, et al.
Publicado: (2022)

Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders
por: Rodríguez-Landa, Juan Francisco, et al.
Publicado: (2023)

Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches
por: Kosel, Markus, et al.
Publicado: (2022)

Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders
por: Lee, Hyeong-Min, et al.
Publicado: (2016)

Novel Oncology Therapeutics: Targeted Drug Delivery for Cancer
por: Tzakos, Andreas G., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_q8gv13ii9278ge14cbtlo2uttg